* A systematic review of existing literature, incorporating 62 studies, evaluated diagnostic tools, imaging techniques, molecular markers, and treatment options for PDTC, revealing significant variance in diagnostic criteria and treatment recommendations.
* The study found prevalent molecular markers, such as TERT (41%), BRAF (28%), and P53 (25%), while highlighting that surgical treatment is advised for early-stage PDTC, although opinions are divided on other treatment methods, with a notable case fatality rate of up to 31%.